Free Trial

Fresh2 Group (FRES) Competitors

$1.23 -0.15 (-10.83%)
(As of 12/17/2024 ET)

FRES vs. ACON, MDXH, NTRA, LH, DGX, EXAS, RDNT, GH, VCYT, and FTRE

Should you be buying Fresh2 Group stock or one of its competitors? The main competitors of Fresh2 Group include Aclarion (ACON), MDxHealth (MDXH), Natera (NTRA), Laboratory Co. of America (LH), Quest Diagnostics (DGX), Exact Sciences (EXAS), RadNet (RDNT), Guardant Health (GH), Veracyte (VCYT), and Fortrea (FTRE). These companies are all part of the "medical laboratories" industry.

Fresh2 Group vs.

Fresh2 Group (NASDAQ:FRES) and Aclarion (NASDAQ:ACON) are both small-cap multi-sector conglomerates companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, community ranking, media sentiment, analyst recommendations and dividends.

Aclarion has a consensus target price of $1.30, suggesting a potential upside of 1,055.56%. Given Aclarion's higher possible upside, analysts plainly believe Aclarion is more favorable than Fresh2 Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresh2 Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00
Aclarion
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Aclarion has lower revenue, but higher earnings than Fresh2 Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresh2 Group$16.98M0.07-$14.77MN/AN/A
Aclarion$49.29K23.81-$4.91MN/AN/A

Aclarion received 3 more outperform votes than Fresh2 Group when rated by MarketBeat users. However, 100.00% of users gave Fresh2 Group an outperform vote while only 80.00% of users gave Aclarion an outperform vote.

CompanyUnderperformOutperform
Fresh2 GroupOutperform Votes
1
100.00%
Underperform Votes
No Votes
AclarionOutperform Votes
4
80.00%
Underperform Votes
1
20.00%

0.4% of Fresh2 Group shares are held by institutional investors. Comparatively, 7.5% of Aclarion shares are held by institutional investors. 26.2% of Fresh2 Group shares are held by company insiders. Comparatively, 1.5% of Aclarion shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Fresh2 Group has a net margin of 0.00% compared to Aclarion's net margin of -12,845.05%. Fresh2 Group's return on equity of 0.00% beat Aclarion's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresh2 GroupN/A N/A N/A
Aclarion -12,845.05%-422.87%-201.15%

Fresh2 Group has a beta of 1.24, meaning that its share price is 24% more volatile than the S&P 500. Comparatively, Aclarion has a beta of 0.44, meaning that its share price is 56% less volatile than the S&P 500.

In the previous week, Aclarion had 3 more articles in the media than Fresh2 Group. MarketBeat recorded 3 mentions for Aclarion and 0 mentions for Fresh2 Group. Fresh2 Group's average media sentiment score of 1.87 beat Aclarion's score of 0.47 indicating that Fresh2 Group is being referred to more favorably in the media.

Company Overall Sentiment
Fresh2 Group Very Positive
Aclarion Neutral

Summary

Fresh2 Group beats Aclarion on 10 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FRES vs. The Competition

MetricFresh2 GroupMedical laboratories IndustryMulti-Sector SectorNASDAQ Exchange
Market Cap$1.11M$2.93B$16.97B$9.31B
Dividend YieldN/A11.01%3.05%4.06%
P/E RatioN/A16.2612.0717.55
Price / Sales0.07210.804.48139.48
Price / CashN/A472.0913.0737.95
Price / Book-0.385.222.244.92
Net Income-$14.77M-$32.86M$882.38M$225.78M
7 Day Performance-3.55%-2.72%-2.07%-1.47%
1 Month Performance22.23%10.77%-2.02%5.36%
1 Year Performance-84.58%17.27%-9.57%22.71%

Fresh2 Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FRES
Fresh2 Group
N/A$1.23
-10.8%
N/A-82.8%$1.11M$16.98M0.0075Positive News
Gap Down
ACON
Aclarion
2.1642 of 5 stars
$0.17
+6.1%
$1.30
+647.1%
-96.9%$1.82M$80,000.000.007Gap Down
MDXH
MDxHealth
2.6421 of 5 stars
$2.20
+9.5%
$7.00
+218.2%
-92.4%$0.00$70.19M0.00300
NTRA
Natera
2.1102 of 5 stars
$167.80
-2.2%
$140.59
-16.2%
+189.4%$22.15B$1.08B0.003,293
LH
Laboratory Co. of America
4.9758 of 5 stars
$236.00
+1.5%
$255.92
+8.4%
+4.6%$19.74B$12.16B44.9867,000Analyst Forecast
Positive News
DGX
Quest Diagnostics
4.8482 of 5 stars
$158.16
+0.5%
$164.58
+4.1%
+13.1%$17.65B$9.54B21.4248,000Analyst Upgrade
EXAS
Exact Sciences
4.6063 of 5 stars
$61.80
-1.1%
$75.29
+21.8%
-7.8%$11.44B$2.50B0.006,600Short Interest ↓
RDNT
RadNet
4.0338 of 5 stars
$78.92
-3.3%
$84.75
+7.4%
+114.5%$5.84B$1.62B0.0010,288Positive News
GH
Guardant Health
3.8154 of 5 stars
$36.37
-1.4%
$40.60
+11.6%
+26.4%$4.49B$692.26M-8.561,779News Coverage
Positive News
VCYT
Veracyte
4.1747 of 5 stars
$42.76
-3.1%
$41.13
-3.8%
+53.8%$3.31B$361.05M0.00790Positive News
FTRE
Fortrea
2.2351 of 5 stars
$22.53
+4.0%
$24.00
+6.5%
-37.4%$2.02B$3.11B0.0018,000

Related Companies and Tools


This page (NASDAQ:FRES) was last updated on 12/17/2024 by MarketBeat.com Staff
From Our Partners